Crossref

1. Cost-effectiveness of osimertinib in the treatment of advanced EGFR-mutated non-small cell lung cancer: a systematic review

- Shahin Nargesi

- Zeinab Dolatshahi

- Aziz Rezapour

- Vahid Alipour

- Aghdas Souresrafil

- Hiro Farabi

- Seyed Arash Javadmoosavi

- Mandana Safakhah

- Najmeh Moradi

2. Enhanced myometrial vascularity and AVM: A review on diagnosis and management

- Behnaz Moradi

- Masoumeh Banihashemian

- Nahid Sadighi

- Elham Shirali

- Shady Abdelsattar Saleem

- Ehsan Najafi